Global AI Healthcare Weekly: $200M for Cancer Therapeutics, AI Diagnostic Platforms, and Surgical Robotics See Major Breakthroughs [20250908]

AI Medical Field Welcomes New Round of Capital Surge This Week:Treeline Biosciences Secures Additional $200 Million in Financing for New Cancer Drug，Enveda Biosciences Reaches Unicorn Status at $150 Million，Ronovo Surgical, a surgical robotics company, completes $67 million Series D financing. At the policy level,The US, UK, and South Korea are all promoting the nationwide implementation and strategic support of AI healthcare., showing that the deep integration of AI technology and the medical industry is accelerating globally.

1.AIMedical Financing Events

1. AIDriven New Drugs and Therapies

l Treeline

Financing Amount:2Billion US dollars

Round: Not specified (Additional financing)

TreelineHeadquartered in the United States, it is aFocused on Developing Cancer TreatmentsBiotechnology company. The company aims to integrate powerful computational biology with high-throughput experiments.Precisely identify and validate new anticancer targets, committed to developing the next generation of transformative oncology therapies., to meet unmet clinical needs.9Month3Day, the company announced that it has obtained2Million-dollar additional financing, and at the same time began its first clinical trials. The company uses advanced computational methods and experimental platforms to accelerate the discovery and development of tumor drugs. The funds from this round will be used to advance clinical projects and accelerate the development of novel cancer therapies.

Source of the news:https://www.businesswire.com/news/home/20250903916944/en/Treeline-Announces-First-Clinical-Trials-and-Secures-%24200M-in-Additional-Funding

l Enveda Biosciences

Financing Amount:1.5Billion US dollars

Round:DWheel

Enveda BiosciencesFounded in2019Year, headquartered in Colorado, USA, is a company utilizingAIAnd phytochemical technology to develop new drugs. The company relies on its unique platformMining drug clues from natural compounds and combining traditional medical wisdom with modern artificial intelligence has opened up a new path for drug discovery., demonstrating enormous therapeutic potential.2025Year9Month4Day, the company announced the completion1.5Billion US dollarsDround of financing, pushing the company's valuation beyond the unicorn threshold. This round of financing was led byKinnevikLeading the investment,Fidelity Management & Research Company and other institutions participated in the investment. The funds will be used to advance the core drug pipeline, including patient enrollment and clinical trials for its lead programs, and to enhance R&D capabilities.

Source of the news:https://www.businesswire.com/news/home/20250904184822/en/Enveda-Raises-%24150M-Series-D-Funding-to-Reach-Unicorn-Status-Enrolls-First-Patient-in-Lead-Program-and-Adds-Mikael-Dolsten-to-Board-of-Directors

l ArcaScience

Financing Amount: Approximately700Million USD

Round: Seed Round/Early Stage

ArcaScienceIs a French start-up company focused onWillAIBenefits Applied in Drug Development-Risk (benefit-risk) Evaluation and Balance AnalysisThe company is dedicated to solving the most critical decision-making challenges in drug development by using quantitative analysis to help pharmaceutical companies evaluate drug potential more scientifically, thereby increasing R&D success rates and optimizing resource allocation.2025Year9Month3Day, the company disclosed the completion of approximately700Million USD in financing, byThe Moon VentureLed by, with participants includingPléiade Venture、Plug&Play Venturesto drive the platform's expansion and productization in the European and American markets, while planning to launch patient-focused solutions and collaborate with several large pharmaceutical companies on partnerships and pilot programs.

Source of the news:https://www.pharmiweb.com/press-release/2025-09-04/arcascience-raises-7m-to-transform-drug-development-with-ai-powered-benefit-risk-intelligence-1

l Molecular You

Financing Amount: Approximately690Ten Thousand Canadian Dollars

Round:AWheel

Molecular YouHeadquartered in Canada, focusing onBy measuring hundreds of biomarkers in combinationAIDriven insights provide predictive health assessments and disease risk detection for individuals and clinical partners.. Its innovative approach goes beyond traditional diagnostics, enabling the earlier detection of health risks and providing a powerful technological tool for personalized medicine and preventive health management, placing it at the forefront of the industry.2025Year9Month3Day, the company announced the completion of approximately690Ten Thousand Canadian DollarsARound of financing, byVoloridge HealthLed by institutions such as . This round of financing will be used to expand business in North America, advance higher-resolution testing products, and deepen commercial channels with insurance companies and clinical partners.

Source of the news:https://www.founderstoday.news/molecular-you-secures-over-6m-series-a/

2. AIMedical Digital Platform and Service Platform

l Predoc

Financing Amount: Approximately3000Million USD

Round: Undisclosed

PredocFounded in the United States, it is a company that builds medical information management platforms with large models and automated workflows as its core.Help hospitals and research networks address inefficiencies in medical record and document retrieval, stitching, and cataloging.. Its platform canDeeply understand and process complex unstructured medical data, significantly improving the efficiency of clinical research and medical operations, is a key tool in driving the digital transformation of healthcare.2025Year9Month2Day,PredocAnnouncing the completion of approximately3000Million USD in financing, byBase10 PartnersEqual-risk funds participated. This round of financing will be used to accelerate product expansion, enter more oncology departments and virtual care networks, and expand market promotion and customer implementation.

Source of the news:https://fortune.com/2025/09/02/predoc-raises-30-million-to-stop-document-chasing-in-healthcare/

l Hello Patient

Financing Amount:2250Million USD

Round:ARound

Hello PatientHeadquartered in the United States, it is aConversational for Outpatient and Primary Care FacilitiesAIPlatform company. Its intelligent virtual assistant can seamlessly manage patient interactions in a natural conversational manner., which not only reduces the administrative burden on medical staff but also significantly improves patients' medical experience and satisfaction through convenient and timely communication.2025Year9Month4Day, the company announced the completion2250Million USDARound of financing, byScale Venture PartnersLead investment.Hello PatientProduct Support24/7Patient liaison, appointment management, and basic consultation aim to improve outpatient accessibility and patient retention while increasing medical institution revenue. The funds from this round will be used to expand the sales team, strengthen technology research and development, and promote integration with more medical practices and insurance providers.

Source of the news:https://www.businesswire.com/news/home/20250904242038/en/Hello-Patient-Raises-%2422.5-Million-Series-A-to-Fix-the-%E2%80%9CFront-Door%E2%80%9D-of-Healthcare-With-Conversational-AI

l Reveal HealthTech

Financing Amount:720Million USD

Round:AWheel

Reveal HealthTechEstablished in approximately2023Year, headquartered in the United States, is aFocuses on providing customized solutions for medical institutions, life sciences, and medical device companiesAIDrive Solutions and Technical ConsultingThe enterprise. The company focuses onCutting-edgeAITechnology Transformed into Tangible Commercial Applications, helping customers accelerate product development, optimize clinical trial processes, and enhance the efficiency and quality of medical services.2025Year9Month, the company announced the completion720Million USDARound of financing, byLeo CapitalLeading investment,Sanos CapitalFollow-on investment. This round of financing will be mainly used to expand its application deployment in U.S. hospitals and clinical research, and strengthen core product lines.BioCanvas, and expand the engineering and clinical services team.

Source of the news:https://yourstory.com/2025/09/funding-reveal-healthtech-push-ai-deeper-into-us-healthcare

l Flax Health

Financing Amount:350Million USD

Round:Pre-Seed

Flax HealthHeadquartered in the United States, focused on developing for professional care institutionsAIDriven automation platform to alleviate heavy administrative and operational burdens. Its solutionsBy automating repetitive tasks such as scheduling, staffing, and compliance documentation, caregivers can focus more on providing high-quality patient care, thereby improving overall operational efficiency.。2025Year9Month4Day, the company announced the completion350Million USDPre-SeedFinancing, byF-Prime CapitalLed by, with participants includingTau VenturesAnd other strategic investors. The funds will mainly be used to expand the R&D team and driveAIThe Implementation of Automation Solutions in More Care Institutions.

Source of the news:https://www.businesswire.com/news/home/20250904722794/en/Flax-Health-Raises-%243.5M-Pre-Seed-to-Bring-AI-Powered-Automation-to-Tackle-Administrative-Burden-in-Skilled-Nursing-Facilities

l XiFin

Financing Amount: Undisclosed

Round: Not specified

XiFinHeadquartered in the United States, it is a company serving laboratory and radiology groups.ProvideAIDriven Revenue Cycle Management and Healthcare Data Exchange Solutions's company. Its platform leverages artificial intelligence to optimizeStreamline the entire financial process from patient registration to final payment, effectively reducing rejections, accelerating cash flow, and lowering administrative costs., providing critical financial and operational support for diagnostic service providers.2025Year9Month3The company announced that it has secured a growth financing round and hired a veteran in medical technology.Jeff MargolisJoin the board of directors. The company's artificial intelligence platform focuses on optimizing healthcare financial processes, including insurance verification, claims processing, and payment management, helping medical institutions improve operational efficiency. The funds from this round will be used to accelerate technology development and market expansion.

Source of the news:https://www.businesswire.com/news/home/20250903291755/en/XiFin-Accelerates-AI-Driven-RCM-Future-with-New-Growth-Funding-and-Addition-of-Visionary-Leader-Jeff-Margolis-to-Its-Board

3. AIRehabilitation Health and Equipment

l Ronovo Surgical

Financing Amount:6700Million USD

Round:DWheel

Ronovo Surgical Established in Shanghai, China, it is a company focused onEndoscopic and Modular Surgical Robots andAIMedical Technology Company for Surgical Assistance Systems. Its innovative modular design breaks through the high cost barriers of traditional surgical robots, with flexible configuration andAIEmpowering surgeons with intelligent assistance, committed to promoting the accessibility and standardization of precision minimally invasive surgery worldwide.2025Year9Month, the company announced the completion of approximately6700Million USDDRound of financing, byJohnson & JohnsonTheJJDCLeading the investment,Lilly Asia Ventures、INCE Capital And Granite AsiaFollow-on investment. This round of financing will be used to accelerate its flagship modular surgical robot platform.CarinaCommercial expansion and strategic market layout in China, while deepening collaboration withJohnson & Johnson MedTechStrategic collaboration in China. In addition, the company has obtainedCarinaIn four major specialties, including general surgery, gynecology, urology, and thoracic surgery,NMPARegistration approval, and is actively promoting regulatory applications and market expansion in Europe and South America.

Source of the news:https://www.businesswire.com/news/home/20250902123456/en

l Model Health

Financing Amount: Approximately80Million Euros

Round:Pre-seed

Model HealthIs a Belgian-A U.S.-co-founded start-up, leveraging computer vision and biomechanical models to transfer lab-level motion and posture analysis capabilities to smartphone video applications.The company's core technology lies in accurately capturing human motion data through ordinary mobile phone cameras, providing professional-grade evaluation tools that are low-cost and remotely usable for fields such as sports rehabilitation and physical training. This breaks the spatial and equipment limitations of traditional motion capture systems. The company’s founding team comes from academic and engineering backgrounds, with primary target customers including rehabilitation and sports clinics, as well as sports teams.2025Year9Month2Day,Model HealthAnnounced the completion of approximately80Million EurosPre-seedFinancing, byAPEX CapitalLed by multiple angel investors and accelerators. This round of financing will be used to accelerate product development, expand customer base in the European and American markets, and promote clinical validation collaborations with sports and rehabilitation institutions.

Source of the news:https://techfundingnews.com/model-health-raises-1m-to-democratise-movement-analysis/

2. Policy News

[United KingdomNHSChina's Stroke DeploymentAIImaging Diagnosis: National Routine Application Brings New Requirements for Compliance and Empirical Evaluation

2025Year9Month1Day, the National Health Service (NHS) of the United Kingdom (NHS England) AnnounceAcross England107Home Stroke Center Deploys a BrainCTImagingAIAuxiliary Diagnostic Tool; Official data shows that the technology can reduce the average time from diagnosis to treatment for patients from about140Minutes shortened to79minutes, and the proportion of full recovery (no or mild disability) from16%Upgrade to48%. As one of the first in the UK to be included in the routine treatment pathway nationwide, the clinicalAIOne of the tools, this initiative not only demonstratesAIThe actual value in emergency treatment also means that the healthcare system needs to address institutional requirements such as clinical responsibility allocation, compliance framework updates, and ongoing evidence-based assessments.

Source:https://www.theguardian.com/society/2025/sep/01/stroke-centres-in-england-given-ai-tool-that-will-help-50-of-patients-recover 

【NIH Common FundLaunchPRIMED-AI: Promote the integration of imaging and multimodal data, provide direct funding channels]

2025Year9Month1On a certain day, the National Institutes of Health (NIH) Subordinate toCommon FundGo onlinePRIMED-AI（Precision Medicine with AI: Integrating Imaging with Multimodal Data) Project page and funding framework. The plan focuses on“Imaging+Multimodal Health Data”The integrated application, and released the projectPlaybookAndNOFOCall for Content, EmphasizingAIRobustness, interpretability, and cross-data linkage of the modelFDAThe importance of preparing for regulatory oversight in advance.As a clear federal funding channel,PRIMED-AIFor medical research or clinical translation that is currently being plannedAIThe team provided direct guidance, which is expected to accelerate the integration of multimodal approaches in the U.S. academic and industrial sectors.AIApplication Landing and Standardization Exploration。

Source:https://commonfund.nih.gov/primed-ai

[Korea Establishes NationalAIStrategic Committee: Healthcare Listed as a High-Impact Industry, Signaling Policy Resource Tilt

2025Year9Month2Day,The Korean government officially established with cabinet approval“CountryAIStrategic Committee”, an institution led directly by the president and incorporating representatives from multiple ministries and the industrial sector, aims to coordinateAIStrategy, resource allocation, and regulatory coordination. Healthcare is explicitly listed as“High Impact/High Priority”One of the industries, meaning that future related funding support, pilot projects, and approval pathways may be strengthened and optimized. This move not only reflects Korea's acceleration at the national level.AIStrategic layout, as well as plans to enter the South Korean market or collaborate with South Korean partners in the medical fieldAIEnterprises release positive policy signals.

Source:https://www.telecomreviewasia.com/news/policy-news/14423-south-korea-launches-national-ai-strategy-committee/